- Home
- VRNA vs AQN Comparison
VRNA vs AQN Comparison
Compare VRNA & AQN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- AQN
- Stock Information
- Founded
- VRNA 2005
- AQN 1988
- Country
- VRNA United Kingdom
- AQN Canada
- Employees
- VRNA N/A
- AQN N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- AQN Electric Utilities: Central
- Sector
- VRNA Health Care
- AQN Utilities
- Exchange
- VRNA Nasdaq
- AQN Nasdaq
- Market Cap
- VRNA 3.4B
- AQN 3.6B
- IPO Year
- VRNA 2017
- AQN 1998
- Fundamental
- Price
- VRNA $51.89
- AQN $4.40
- Analyst Decision
- VRNA Strong Buy
- AQN Hold
- Analyst Count
- VRNA 7
- AQN 7
- Target Price
- VRNA $50.57
- AQN $5.96
- AVG Volume (30 Days)
- VRNA 1.4M
- AQN 6.7M
- Earning Date
- VRNA 02-27-2025
- AQN 03-07-2025
- Dividend Yield
- VRNA N/A
- AQN 9.37%
- EPS Growth
- VRNA N/A
- AQN N/A
- EPS
- VRNA N/A
- AQN N/A
- Revenue
- VRNA $5,624,000.00
- AQN $2,614,452,000.00
- Revenue This Year
- VRNA N/A
- AQN N/A
- Revenue Next Year
- VRNA $550.30
- AQN N/A
- P/E Ratio
- VRNA N/A
- AQN N/A
- Revenue Growth
- VRNA 1127.95
- AQN 1.88
- 52 Week Low
- VRNA $11.39
- AQN $4.19
- 52 Week High
- VRNA $55.42
- AQN $6.79
- Technical
- Relative Strength Index (RSI)
- VRNA 64.25
- AQN 44.75
- Support Level
- VRNA $43.44
- AQN $4.19
- Resistance Level
- VRNA $55.42
- AQN $4.43
- Average True Range (ATR)
- VRNA 3.32
- AQN 0.12
- MACD
- VRNA 0.40
- AQN 0.01
- Stochastic Oscillator
- VRNA 70.52
- AQN 50.00
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About AQN Algonquin Power & Utilities Corp.
Algonquin Power & Utilities Corp, a parent company of Liberty, is a diversified international generation, transmission, and distribution utility with over $16 billion of total assets. Through its two business groups, the Regulated Services Group and the Renewable Energy Group, AQN is committed to providing safe, secure, reliable, cost-effective, and sustainable energy and water solutions through its portfolio of electric generation, transmission, and distribution utility investments to over one million customer connections, largely in the United States and Canada. AQN provides renewable energy through its portfolio of long-term contracted wind, solar, and hydroelectric generating facilities.